查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球傳染病診斷市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342965

全球傳染病診斷市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Infectious Respiratory Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

全球傳染病診斷市場需求預計將從 2022 年的 659.2 億美元增至 2030 年的近 854.1 億美元，2023-2030 年研究期間年複合成長率為 2.92%。

呼吸道傳染病是由病毒、細菌或其他病原微生物引起的。當人打噴嚏、咳嗽、說話或大笑時，可感染呼吸系統的微生物會通過唾液和粘液（也稱為呼吸道分泌物）迅速傳播。一些常見的傳染性呼吸道疾病有流感、麻疹、肺結核、百日咳、風疹等。

市場動態：

呼吸道疾病的患病率不斷上升、先進分子生物學技術的使用不斷增加、老年人口不斷增加，以及政府和低調組​​織為降低傳染病風險而採取的舉措，推動了傳染性呼吸道疾病診斷市場的發展。此外，自檢產品和照護端產品的使用增加將促進市場成長。為了滿足對傳染病診斷的診斷和耗材日益成長的需求，創新技術的發展不斷發展，這是推動呼吸道疾病診斷市場成長的另一個因素。肺部疾病（包括結核病和肺炎）以及其他慢性阻塞性肺部疾病（如慢性支氣管炎、肺氣腫和哮喘）病例的激增將促進市場成長。此外，對檢測下呼吸道傳染病的診斷測試和工具的需求不斷成長將促進市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球傳染性呼吸道疾病診斷市場的每個細分市場進行了包容性評估。傳染性呼吸道疾病診斷行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的傳染病診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。傳染性呼吸道疾病診斷市場的主要參與者包括 Abbott、Thermo Fisher Scientific Inc.、Koninklijke Philips NV、F. Hoffmann-La Roche Ltd.、bioMerieux SA、BD、Quidel Corporation、QIAGEN、Danaher、Siemens Healthcare GmbH。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：傳染性呼吸道疾病診斷 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析：按產品類型
    • 按樣本類型進行的市場吸引力分析
    • 市場吸引力分析：按應用分類
    • 按技術分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

5 COVID-19 爆發的影響分析

第 6 章：全球傳染性呼吸道疾病診斷市場分析：按產品類型

  • 概述：按產品類型
  • 歷史和預測數據
  • 分析：按產品類型
  • 儀器（成像測試、呼吸測量設備、其他儀器）
  • 耗材
  • 服務

第 7 章：全球傳染性呼吸道疾病診斷市場分析：按樣本類型

  • 按樣本類型概述
  • 歷史和預測數據
  • 按樣本類型分析
  • 唾液
  • 鼻咽拭子 (NPS)
  • 前鼻區
  • 血
  • 其他

第 8 章：全球傳染性呼吸道疾病診斷市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 新冠肺炎
  • 流感
  • RSV（呼吸道合胞病毒）
  • 結核
  • 鏈球菌檢測
  • 其他呼吸道疾病檢測

第 9 章：全球傳染性呼吸道疾病診斷市場分析：按技術分類

  • 按技術概述
  • 歷史和預測數據
  • 按技術分析
  • 免疫分析
  • 分子診斷
  • 微生物學
  • 其他技術

第 10 章：全球傳染性呼吸道疾病診斷市場分析：按最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 診斷實驗室
  • 醫生辦公室
  • 其他最終用戶

第 11 章：全球傳染性呼吸道疾病診斷市場分析：按地理位置

  • 頂級公司股票分析
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：傳染性呼吸系統疾病診斷公司的競爭格局

  • 傳染病診斷市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Koninklijke Philips NV
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • bioMerieux SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BD
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Quidel Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • QIAGEN
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siemens Healthcare GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR11219207

The global demand for Infectious Respiratory Disease Diagnostics Market is presumed to reach the market size of nearly USD 85.41 BN by 2030 from USD 65.92 BN in 2022 with a CAGR of 2.92% under the study period 2023 - 2030.

Respiratory infectious diseases are caused by viruses, bacteria, or other pathogenic microbes. Microbes that can infect the respiratory system are rapidly spread through saliva & mucus (also referred to as respiratory secretions) when a person sneezes, coughs, talks or laughs. Some common infectious respiratory diseases are influenza, measles, tuberculosis, pertussis, rubella, etc.

MARKET DYNAMICS:

The market for infectious respiratory disease diagnostics is driven by an increasing prevalence of respiratory diseases, increasing use of advanced molecular biology techniques, a rising elderly population, and initiatives taken by the government and low-profile organizations to decrease the risk of infectious diseases. Moreover, increasing usage of self-testing products & point of care products will flourish the market growth. The rise in the development of innovative techniques for meeting the increasing demand for diagnostics & consumables for the diagnosis of infectious diseases is another factor driving the growth of the respiratory disease diagnostics market. The surge in cases of lung diseases, including tuberculosis & pneumonia and other chronic obstructive pulmonary disorders like chronic bronchitis, emphysema, and asthma, will foster market growth. Furthermore, rising demand for diagnostic tests & tools to detect lower respiratory infectious disease will augment the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of infectious respiratory disease diagnostics. The growth and trends of infectious respiratory disease diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the infectious respiratory disease diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
  • Consumables
  • Services

By Sample Type

  • Saliva
  • Nasopharyngeal Swabs (NPS)
  • Anterior Nasal Region
  • Blood
  • Others

By Application

  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
  • Tuberculosis
  • Streptococcus Testing
  • Other Respiratory Disease Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Other Technologies

By End-Use

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Infectious Respiratory Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the infectious respiratory disease diagnostics market include Abbott, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, Quidel Corporation, QIAGEN, Danaher, Siemens Healthcare GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

  • 7.1 Overview by Sample Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Sample Type
  • 7.4 Saliva Historic and Forecast Sales by Regions
  • 7.5 Nasopharyngeal Swabs (NPS) Historic and Forecast Sales by Regions
  • 7.6 Anterior Nasal Region Historic and Forecast Sales by Regions
  • 7.7 Blood Historic and Forecast Sales by Regions
  • 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 COVID-19 Historic and Forecast Sales by Regions
  • 8.5 Influenza Historic and Forecast Sales by Regions
  • 8.6 RSV (Respiratory Syncytial Virus) Historic and Forecast Sales by Regions
  • 8.7 Tuberculosis Historic and Forecast Sales by Regions
  • 8.8 Streptococcus Testing Historic and Forecast Sales by Regions
  • 8.9 Other Respiratory Disease Testing Historic and Forecast Sales by Regions

9 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 9.1 Overview by Technology
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Technology
  • 9.4 Immunoassay Historic and Forecast Sales by Regions
  • 9.5 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 9.6 Microbiology Historic and Forecast Sales by Regions
  • 9.7 Other technologies Historic and Forecast Sales by Regions

10 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Hospitals Historic and Forecast Sales by Regions
  • 10.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Physician Offices Historic and Forecast Sales by Regions
  • 10.7 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS COMPANIES

  • 12.1. Infectious Respiratory Disease Diagnostics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Abbott
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Koninklijke Philips N.V.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. F. Hoffmann-La Roche Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. bioMerieux SA
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. BD
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Quidel Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. QIAGEN
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Danaher
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Siemens Healthcare GmbH
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Infectious Respiratory Disease Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Infectious Respiratory Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Infectious Respiratory Disease Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Sample Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.